BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silva VL, Ruiz A, Ali A, Pereira S, Seitsonen J, Ruokolainen J, Furlong F, Coulter J, Al-Jamal WT. Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids. Int J Pharm 2021;607:121018. [PMID: 34416329 DOI: 10.1016/j.ijpharm.2021.121018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Petrić T, Sabol M. Let’s Go 3D! New Generation of Models for Evaluating Drug Response and Resistance in Prostate Cancer. IJMS 2023;24:5293. [DOI: 10.3390/ijms24065293] [Reference Citation Analysis]
2 Qian Z, Zhang Y, Yuan J, Gong S, Chen B. Current applications of nanomaterials in urinary system tumors. Front Bioeng Biotechnol 2023;11:1111977. [PMID: 36890910 DOI: 10.3389/fbioe.2023.1111977] [Reference Citation Analysis]
3 Ojha A, Jaiswal S, Bharti P, Mishra SK. Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review. Cancers (Basel) 2022;15. [PMID: 36612158 DOI: 10.3390/cancers15010162] [Reference Citation Analysis]
4 Gomes ER, Franco MS. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy. Pharmaceutics 2022;14:105. [PMID: 35057001 DOI: 10.3390/pharmaceutics14010105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]